Webcast, Event, or Conference

Home»Webcast, Event, or Conference
15 11, 2019

Eiger to Present at Jefferies 2019 London Healthcare Conference

2019-11-15T17:27:31+00:00

Eiger to Present at Jefferies 2019 London Healthcare Conference PALO ALTO, Calif. – November 15, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will present a corporate update at the Jefferies 2019 London Healthcare Conference on November [...]

Eiger to Present at Jefferies 2019 London Healthcare Conference2019-11-15T17:27:31+00:00
28 09, 2019

Eiger to Present at Cantor 2019 Global Healthcare Conference

2019-09-28T15:38:30+00:00

Eiger to Present at Cantor 2019 Global Healthcare Conference PALO ALTO, Calif. – September 27, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will present a corporate update at the Cantor 2019 Global Healthcare Conference on October [...]

Eiger to Present at Cantor 2019 Global Healthcare Conference2019-09-28T15:38:30+00:00
29 08, 2019

Eiger BioPharmaceuticals to Participate in September Conferences

2019-08-29T20:16:25+00:00

Eiger BioPharmaceuticals to Participate in September Conferences PALO ALTO, Calif. – August 29, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will participate in the following upcoming investor conferences in September: Baird 2019 Global Healthcare Conference at the [...]

Eiger BioPharmaceuticals to Participate in September Conferences2019-08-29T20:16:25+00:00
6 08, 2019

Eiger BioPharmaceuticals to Participate in Investor Conferences in August

2019-08-06T18:37:29+00:00

Eiger BioPharmaceuticals to Participate in Investor Conferences in August PALO ALTO, Calif. – August 5, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will participate in two upcoming investor conferences in August. BTIG Biotechnology Conference at St. Regis [...]

Eiger BioPharmaceuticals to Participate in Investor Conferences in August2019-08-06T18:37:29+00:00
30 05, 2019

Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference

2019-05-30T14:39:10+00:00

Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference PALO ALTO, Calif., May 30, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President and CEO, will present a corporate update at the Jefferies 2019 Global Healthcare [...]

Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference2019-05-30T14:39:10+00:00
30 04, 2019

Eiger Bio to Present at Upcoming ChinaBio® Partnering Forum 2019

2019-04-30T13:24:14+00:00

Eiger Bio to Present at Upcoming ChinaBio® Partnering Forum 2019 PALO ALTO, Calif., April 30, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President and CEO, will participate and present a corporate update at the ChinaBio® Partnering [...]

Eiger Bio to Present at Upcoming ChinaBio® Partnering Forum 20192019-04-30T13:24:14+00:00
26 03, 2019

Eiger BioPharmaceuticals to Participate in Conferences in April

2019-03-26T13:24:24+00:00

Eiger BioPharmaceuticals to Participate in Conferences in April PALO ALTO, Calif. – March 26, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will present at upcoming investor, scientific, and orphan drug conferences in April. C. Wainwright Global [...]

Eiger BioPharmaceuticals to Participate in Conferences in April2019-03-26T13:24:24+00:00
20 03, 2019

Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019

2019-03-20T13:29:54+00:00

Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019 PALO ALTO, Calif., March 20, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President and CEO, will present a corporate update at the [...]

Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 20192019-03-20T13:29:54+00:00
13 03, 2019

Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019

2019-03-13T14:34:05+00:00

Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019 36% Durable Virologic Response at 24 Weeks Post-Treatment PALO ALTO, Calif., March 13, 2019 -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced a late-breaker [...]

Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 20192019-03-13T14:34:05+00:00
11 03, 2019

Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit

2019-03-11T15:07:06+00:00

Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit PALO ALTO, Calif., March 11, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President and CEO, will present a corporate update at the Jefferies [...]

Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit2019-03-11T15:07:06+00:00